Pre-Exposure Prophylactics (PrEP) & Post Exposure Prophylactics (PEP)

PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis) are two important HIV prevention strategies. PrEP involves the use of antiretroviral medications by individuals who are at high risk of contracting HIV before potential exposure to the virus. These medications, taken consistently, can significantly reduce the risk of HIV transmission. PrEP is particularly recommended for individuals in serodiscordant relationships (where one partner is HIV-positive), men who have sex with men, and others at elevated risk.

On the other hand, PEP is a short-term treatment initiated after a potential exposure to HIV, such as through unprotected sex or needle sharing. PEP involves taking a combination of antiretroviral drugs within 72 hours of the exposure and continuing the regimen for 28 days. PEP is not guaranteed to prevent HIV infection, but when administered promptly, it can substantially decrease the likelihood of the virus establishing itself in the body.

Both PrEP and PEP play crucial roles in comprehensive HIV prevention efforts, providing additional tools to protect individuals at different stages of potential exposure to the virus. It's important for individuals to consult with healthcare professionals to determine the most appropriate prevention strategy based on their specific circumstances and risk factors.